SCHEMBL3659233

SCHEMBL3659233

Cc1ccc(-c2cccc(C(=O)O)c2-n2cncn2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.41
GAA P10253 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
MCL1 Q07820 3/20 0.39
BAD Q92934 2/20 0.39
PDE4B Q07343 1/20 0.38
LTB4R2 Q9NPC1 1/20 0.37
BRS3 P32247 1/20 0.37
HNF4A P41235 1/20 0.37
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 2/20 0.36
MYC P01106 1/20 0.36
AKR1C3 P42330 1/20 0.36
KDM4E B2RXH2 1/20 0.36
AKR1C2 P52895 1/20 0.35
AKR1C1 Q04828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28184030 0.75 POLB (0.43) GAAALDH1A1SMN1; SMN2LMNAPOLB
SCHEMBL31175286 0.75 POLB (0.46) NPC1RAB9AKMT2APDE4BALDH1A1
SCHEMBL21816306 0.75 POLB (0.46) NPC1RAB9AKMT2APDE4BALDH1A1
SCHEMBL31402608 0.70 KMT2A (0.60) NPC1GAARAB9AKMT2AMCL1
SCHEMBL372 0.70 KMT2A (0.60) NPC1GAARAB9AKMT2AMCL1
SCHEMBL31175307 0.70 CYP3A4 (0.46) KMT2AALDH1A1SMN1; SMN2POLBMYC
SCHEMBL21816252 0.70 POLB (0.43) KMT2AALDH1A1SMN1; SMN2POLBMYC
SCHEMBL11142513 0.70 POLB (0.54) NPC1GAARAB9AKMT2AMCL1
SCHEMBL16720212 0.69 NPC1 (0.44) NPC1RAB9AKMT2AHNF4AALDH1A1
SCHEMBL15048857 0.69 NPC1 (0.44) NPC1GAARAB9AKMT2AMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2225213-A1 TRIAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND /OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-08 EP disclosed
WO-2009077366-A1 TRIAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND /OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-06-25 WO disclosed